This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Orion Biotechnology Presented at the 3rd GPCR-Targeted Drug Discovery Summit in Boston
13.03.2024
Ottawa, Canada, May 10, 2022 (GLOBE NEWSWIRE) — Orion Biotechnology Canada Ltd, a drug discovery and development company unlocking the therapeutic potential of G Protein-Coupled...
Orion Biotechnology featured on BestStock.com
29.08.2023
Lorem ipsum dolor sit amet consectetur. Ultrices pretium sollicitudin aliquam interdum sed set amet in... Lorem ipsum dolor sit amet consectetur. Ultrices pretium sollicitudin aliquam...
Orion Biotechnology Completes Discovery of First-in-Class Molecule Against Undrugged GPCR Target in Four Months
18.07.2023
Ottawa, Canada, May 10, 2022 (GLOBE NEWSWIRE) — Orion Biotechnology Canada Ltd, a drug discovery and development company unlocking the therapeutic potential of G Protein-Coupled...
Orion Biotechnology Presenting at the 2nd GPCR-Targeted Drug Discovery Summit in Boston
18.02.2023
Ottawa, Canada, May 10, 2022 (GLOBE NEWSWIRE) — Orion Biotechnology Canada Ltd, a drug discovery and development company unlocking the therapeutic potential of G Protein-Coupled...